Diabetes
| Weight loss
Diabetes
Weight loss

SURMOUNT-4 Trial results: the impact of tirzepatide on maintenance of weight reduction and benefits of continued therapy

book_2 Source: EASD 2023 - Oral Presentation
calendar_today Published on Medfyle: October 2023
import_contacts 7 min
headphones 5 min

In this medfyle

Tirzepatide demonstrated significant and superior weight loss compared to placebo in SURMOUNT-4.

Expert commentary

Prof. Francesco Giorgino

University of Bari Aldo Moro,
BA, Italy

About this Medfyle
Read more arrow_downward Hide arrow_upward

This is a summary of a presentation given at the EASD 2023 Annual Meeting. The content is developed by Infomedica in collaboration with the Diabetes Education Study Group (DESG).

The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the DESG.

©2023 Infomedica-Medfyle. All rights reserved.

Interview

Feedback